CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
blank image Search
blank image blank image
blank image
  Advanced Search

Journal Home
About the Journal
Editorial Structure
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Sample Issue
Call for Papers
For Authors
General Information
Submit Article
Author Instructions
Open Access
For Referees
Referee Guidelines
Review an Article
Annual Referee Index
For Subscribers
Subscription Prices
Customer Service
Library Recommendation
For Advertisers

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter logo LinkedIn

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.


Article << Previous     |     Next >>   Contents Vol 7(3)

US physicians’ intentions regarding impact of human papillomavirus vaccine on cervical cancer screening

Charlene Wong A C, Zahava Berkowitz A, Mona Saraiya A, Louise Wideroff B, Vicki B. Benard A

A Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop K-55, Atlanta, GA 30341, USA.
B National Cancer Institute, 6001 Executive Blvd., Suite 5153 MSC 9589, Bethesda, MD 20892-9589, USA.
C Corresponding author. Email: hrl5@cdc.gov
PDF (171 KB) $25
 Export Citation


Background: US cervical cancer screening recommendations have not changed since the human papillomavirus (HPV) vaccine introduction in 2006, but epidemiological and cost-effectiveness studies indicate that recommendations will need to change for fully vaccinated women. We evaluated physician intentions regarding HPV vaccine’s impact on future screening. Methods: A nationally representative sample of 1212 primary care physicians was surveyed in 2006–2007 (response rate: 67.5%). Our study included 1114 physicians who provided Pap testing. Questions covered Pap test screening practices and intentions regarding HPV vaccine’s impact on screening. Distribution differences were assessed using χ2 statistics; multivariate analyses were performed. Results: Overall, 40.7% (95% confidence interval (CI): 37.6–43.8%) of physicians agreed that the HPV vaccine will affect screening initiation, and 38.2% (35.0–41.5%) agreed that vaccination will affect screening frequency. Significant differences in responses were found by specialty; internists were more likely to agree that vaccination would impact screening than other specialties. Belief in the effectiveness of new screening technologies was associated with intention to change screening initiation (odds ratio (OR) = 1.66 (1.20–2.31)) and frequency (OR = 1.99 (1.40–2.83)). Adherence to current Pap test screening interval guidelines was associated with intention to change screening frequency (OR = 1.39 (1.01–1.91)). Conclusions: Many providers anticipate adjusting screening for vaccinated women, but a significant group believes nothing will change or are unsure. The present study provides important baseline data on intentions in the period preceding widespread vaccine diffusion and may help explain current and future trends in practice patterns.

Keywords: Pap cytology, prevention.

Subscriber Login

Legal & Privacy | Contact Us | Help


© CSIRO 1996-2016